# Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome

> **NCT04447846** · PHASE2 · COMPLETED · sponsor: **Anne Comi, MD** · enrollment: 11 (actual)

## Conditions studied

- Sturge-Weber Syndrome

## Interventions

- **DRUG:** Cannabidiol

## Key facts

- **NCT ID:** NCT04447846
- **Lead sponsor:** Anne Comi, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2021-08-16
- **Final completion:** 2022-12-09
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04447846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04447846, "Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04447846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*